prednisolone has been researched along with Amyloid Deposits in 1 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ishii, W | 1 |
| Kishida, D | 1 |
| Suzuki, A | 1 |
| Shimojima, Y | 1 |
| Matsuda, M | 1 |
| Hoshii, Y | 1 |
| Ikeda, S | 1 |
1 other study available for prednisolone and Amyloid Deposits
| Article | Year |
|---|---|
A case with rheumatoid arthritis and systemic reactive AA amyloidosis showing rapid regression of amyloid deposition on gastroduodenal mucosa after a combined therapy of corticosteroid and etanercept.
Topics: Aged; Amyloidosis; Antirheumatic Agents; Arthritis, Rheumatoid; Drug Therapy, Combination; Etanercep | 2011 |